论文部分内容阅读
目的 :观察并分析幽门螺旋杆菌相关性胃溃疡的药物治疗方案及临床治疗效果。方法 :选择本院2015年1月-2017年1月间收治的90例幽门螺旋杆菌感染相关性胃溃疡患者为调查对象,并对如上患者实施分组治疗,对照组采取常规三联治疗,观察组则实施四联治疗,各45例。结果:对比治疗总有效率,观察组为95.6%提高显著(P<0.05)。对比两组幽门螺旋杆菌根除率以及复发率,结果提示观察组有明显优异性(P<0.05)。结论 :对幽门螺旋杆菌相关性胃溃疡患者实施四联药物治疗可显著提高该病症的治疗效果,预防复发。
Objective: To observe and analyze the drug treatment of Helicobacter pylori associated gastric ulcer and its clinical effect. Methods: 90 patients with H. pylori-associated gastric ulcer admitted to our hospital from January 2015 to January 2017 were enrolled in this study. Patients in the control group were treated with conventional triple therapy and in the observation group The implementation of quadruple therapy, each 45 cases. Results: Compared with the total effective rate of treatment, 95.6% of the observation group increased significantly (P <0.05). The eradication rate and relapse rate of H. pylori in both groups were compared. The results showed that the observation group had obvious superiority (P <0.05). Conclusion: The quadruple drug treatment of patients with Helicobacter pylori-associated gastric ulcer can significantly improve the curative effect of the condition and prevent recurrence.